308 related articles for article (PubMed ID: 26603783)
21. Critical aspects in reproductive and developmental toxicity testing of environmental chemicals.
Buschmann J
Reprod Toxicol; 2006 Aug; 22(2):157-63. PubMed ID: 16782303
[TBL] [Abstract][Full Text] [Related]
22. Update of OECD DART guidelines with endocrine disruptor relevant endpoints: Practical considerations.
Beekhuijzen M; van Otterdijk F; Wieland W; van Tuyl M; Rijcken RP; Peter B; Emmen H
Reprod Toxicol; 2016 Sep; 64():64-71. PubMed ID: 27063183
[TBL] [Abstract][Full Text] [Related]
23. In silico analysis of nanomaterials hazard and risk.
Cohen Y; Rallo R; Liu R; Liu HH
Acc Chem Res; 2013 Mar; 46(3):802-12. PubMed ID: 23138971
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of OECD screening tests 421 (reproduction/developmental toxicity screening test) and 422 (combined repeated dose toxicity study with the reproduction/developmental toxicity screening test).
Reuter U; Heinrich-Hirsch B; Hellwig J; Holzum B; Welsch F
Regul Toxicol Pharmacol; 2003 Aug; 38(1):17-26. PubMed ID: 12878050
[TBL] [Abstract][Full Text] [Related]
25. Introducing a new standardized nanomaterial environmental toxicity screening testing procedure, ISO/TS 20787: aquatic toxicity assessment of manufactured nanomaterials in saltwater Lakes using Artemia sp. nauplii.
Johari SA; Rasmussen K; Gulumian M; Ghazi-Khansari M; Tetarazako N; Kashiwada S; Asghari S; Park JW; Yu IJ
Toxicol Mech Methods; 2019 Feb; 29(2):95-109. PubMed ID: 30113242
[TBL] [Abstract][Full Text] [Related]
26. Is the risk from nanomaterials perceived as different from the risk of 'chemicals' by the Australian public?
Capon A; Rolfe M; Gillespie J; Smith W
Public Health Res Pract; 2016 Apr; 26(2):. PubMed ID: 27734061
[TBL] [Abstract][Full Text] [Related]
27. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
28. Inhalation toxicity studies: OECD guidelines in relation to REACH and scientific developments.
Arts JH; Muijser H; Jonker D; van de Sandt JJ; Bos PM; Feron VJ
Exp Toxicol Pathol; 2008 Jun; 60(2-3):125-33. PubMed ID: 18455380
[TBL] [Abstract][Full Text] [Related]
29. Nanotechnology and nanomaterials: toxicology, risk assessment, and regulations.
Fan AM; Alexeeff G
J Nanosci Nanotechnol; 2010 Dec; 10(12):8646-57. PubMed ID: 21121378
[TBL] [Abstract][Full Text] [Related]
30. The carcinogenic potential of nanomaterials, their release from products and options for regulating them.
Becker H; Herzberg F; Schulte A; Kolossa-Gehring M
Int J Hyg Environ Health; 2011 Jun; 214(3):231-8. PubMed ID: 21168363
[TBL] [Abstract][Full Text] [Related]
31. Translating Scientific Advances in the AOP Framework to Decision Making for Nanomaterials.
Ede JD; Lobaskin V; Vogel U; Lynch I; Halappanavar S; Doak SH; Roberts MG; Shatkin JA
Nanomaterials (Basel); 2020 Jun; 10(6):. PubMed ID: 32599945
[TBL] [Abstract][Full Text] [Related]
32. [International trend of guidance for nanomaterial risk assessment].
Hirose A
Yakugaku Zasshi; 2013; 133(2):175-80. PubMed ID: 23370509
[TBL] [Abstract][Full Text] [Related]
33. [Importance of researches on chronic effects by manufactured nanomaterials].
Hirose A; Takagi A; Nishimura T; Tsuda H; Sakamoto Y; Ogata A; Nakae D; Hino O; Kanno J
Yakugaku Zasshi; 2011 Feb; 131(2):195-201. PubMed ID: 21297361
[TBL] [Abstract][Full Text] [Related]
34. Facilitating the use of non-standard in vivo studies in health risk assessment of chemicals: a proposal to improve evaluation criteria and reporting.
Beronius A; Molander L; Rudén C; Hanberg A
J Appl Toxicol; 2014 Jun; 34(6):607-17. PubMed ID: 24481642
[TBL] [Abstract][Full Text] [Related]
35. Current state of the implementation of the OECD GLP principles in the OECD member countries and non-member economies in light of the outcome of the 1998-2002 pilot project of mutual joint visits.
Turnheim D
Ann Ist Super Sanita; 2008; 44(4):327-30. PubMed ID: 19351989
[TBL] [Abstract][Full Text] [Related]
36. Regulatory landscape of nanotechnology and nanoplastics from a global perspective.
Allan J; Belz S; Hoeveler A; Hugas M; Okuda H; Patri A; Rauscher H; Silva P; Slikker W; Sokull-Kluettgen B; Tong W; Anklam E
Regul Toxicol Pharmacol; 2021 Jun; 122():104885. PubMed ID: 33617940
[TBL] [Abstract][Full Text] [Related]
37. Practical considerations for conducting ecotoxicity test methods with manufactured nanomaterials: what have we learnt so far?
Handy RD; van den Brink N; Chappell M; Mühling M; Behra R; Dušinská M; Simpson P; Ahtiainen J; Jha AN; Seiter J; Bednar A; Kennedy A; Fernandes TF; Riediker M
Ecotoxicology; 2012 May; 21(4):933-72. PubMed ID: 22422174
[TBL] [Abstract][Full Text] [Related]
38. [Estimation of genetic safety of nanomaterials].
Sycheva LP; Zhurkov VS
Vestn Ross Akad Med Nauk; 2011; (9):72-6. PubMed ID: 22145377
[TBL] [Abstract][Full Text] [Related]
39. [Harmonization with international approaches to guidance documents on methods of assessment of the mutagenic properties of chemical environmental factors].
Zhurkov VS; Sycheva LP; Ingel' FI; Akhal'tseva LV; Iurchenko VV
Gig Sanit; 2013; (6):49-52. PubMed ID: 24624821
[TBL] [Abstract][Full Text] [Related]
40. In vitro genotoxicity testing strategy for nanomaterials and the adaptation of current OECD guidelines.
Doak SH; Manshian B; Jenkins GJ; Singh N
Mutat Res; 2012 Jun; 745(1-2):104-11. PubMed ID: 21971291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
